CA2878496C - Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes - Google Patents

Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes Download PDF

Info

Publication number
CA2878496C
CA2878496C CA2878496A CA2878496A CA2878496C CA 2878496 C CA2878496 C CA 2878496C CA 2878496 A CA2878496 A CA 2878496A CA 2878496 A CA2878496 A CA 2878496A CA 2878496 C CA2878496 C CA 2878496C
Authority
CA
Canada
Prior art keywords
extract
myrtle
composition according
acnes
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2878496A
Other languages
English (en)
French (fr)
Other versions
CA2878496A1 (fr
Inventor
Joelle Luc
Christel Fiorini-Puybaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of CA2878496A1 publication Critical patent/CA2878496A1/fr
Application granted granted Critical
Publication of CA2878496C publication Critical patent/CA2878496C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2878496A 2012-07-09 2013-07-08 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes Active CA2878496C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1256607 2012-07-09
FR1256607A FR2992862B1 (fr) 2012-07-09 2012-07-09 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes
PCT/EP2013/064415 WO2014009325A1 (fr) 2012-07-09 2013-07-08 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes

Publications (2)

Publication Number Publication Date
CA2878496A1 CA2878496A1 (fr) 2014-01-16
CA2878496C true CA2878496C (fr) 2020-12-15

Family

ID=47022816

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2878496A Active CA2878496C (fr) 2012-07-09 2013-07-08 Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes

Country Status (9)

Country Link
US (1) US9808496B2 (https=)
EP (1) EP2869827B1 (https=)
JP (1) JP2015522054A (https=)
BR (1) BR112015000275B1 (https=)
CA (1) CA2878496C (https=)
ES (1) ES2635382T3 (https=)
FR (1) FR2992862B1 (https=)
MX (1) MX355668B (https=)
WO (1) WO2014009325A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
MX2018008569A (es) 2016-01-28 2018-08-16 Kimberly Clark Co Composicion antiadherente contra virus de acido desoxirribonucleico (adn) y metodo para inhibir la adherencia de virus de acido desoxirribonucleico (adn) a una superficie.
MX2018013276A (es) 2016-05-26 2019-03-28 Kimberly Clark Co Composiciones antiadherentes y metodos para inhibir la adherencia de microbios a una superficie.
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
FR3120790B1 (fr) 2021-03-10 2024-03-15 Fabre Pierre Dermo Cosmetique Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes
FR3132632B1 (fr) 2022-02-17 2025-05-23 Fabre Pierre Dermo Cosmetique Composition comprenant un extrait de myrte et un extrait de Tripterygium wilfordii pour lutter contre l’acné des zones non lésionnelles de la peau acnéique
CN116763692A (zh) * 2023-05-26 2023-09-19 广州凡岛网络科技有限公司 一种控油祛痘组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783425B1 (fr) 1998-09-17 2002-06-07 Fabre Pierre Dermo Cosmetique Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie
US20060008538A1 (en) * 2004-07-07 2006-01-12 Wu Jeffrey M Methods of treating the skin
WO2012053010A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin

Also Published As

Publication number Publication date
WO2014009325A1 (fr) 2014-01-16
FR2992862A1 (fr) 2014-01-10
EP2869827B1 (fr) 2017-05-03
CA2878496A1 (fr) 2014-01-16
JP2015522054A (ja) 2015-08-03
BR112015000275A2 (pt) 2017-06-27
BR112015000275B1 (pt) 2021-02-09
MX355668B (es) 2018-04-24
MX2015000276A (es) 2015-07-21
US9808496B2 (en) 2017-11-07
ES2635382T3 (es) 2017-10-03
FR2992862B1 (fr) 2014-10-03
US20150190447A1 (en) 2015-07-09
EP2869827A1 (fr) 2015-05-13

Similar Documents

Publication Publication Date Title
CA2878496C (fr) Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes
KR20160114980A (ko) 아마씨에서 추출한 단백 다당체, 치아씨에서 추출한 단백 다당체 및 폴리글루탐산을 유효성분으로 함유하는 화장료 조성물 및 그 제조방법
FR2779645A1 (fr) Compositions a usage cosmetique ou dermopharmaceutique contenant un melange d'extrait de cafe vert et de beurre de karite
KR102475130B1 (ko) 펜타사이클릭 트리터펜 카페익 액씨드 에스터를 포함하는 피부 보습 또는 피부 미백용 조성물
WO2018146066A1 (fr) Extraits de la liane marsdenia cundurango, compositions cosmetiques les comprenant et leurs utilisations cosmétiques
FR3016127A1 (fr) Composition pour la restauration de l'effet barriere des cellules epitheliales
KR101433823B1 (ko) 부챗말 추출물 또는 분획물을 이용한 피부 외용제 조성물
EP4153305A1 (fr) Hydrolysat de protéines du tourteau des graines de moringa peregrina pour son application en tant que médicament, son procédé d'obtention et compositions pharmaceutiques et dermatologiques
EP3217966A1 (fr) Compositions aux propriétés biocides comprenant des composes extraits de plantes tropicales
KR100531503B1 (ko) 천연원료를 포함하는 화장료 조성물
EP2303301B1 (fr) Compositions a base de plantes et utilisations
WO2022018392A1 (fr) Extrait de fleurs de bombax costatum riche en polysaccharides
KR101326164B1 (ko) 항균성 피부 외용제 조성물
El-Haci et al. Total phenolic content and antioxidant activity of a medicinal plant endemic to the Algerian Sahara
FR2988563A1 (fr) Activite antimicrobienne de ludwigia grandiflora
WO2025012135A1 (fr) Extrait de biomasse d'algues rouges et son utilisation cosmetique pour eliminer les imperfections de la peau
FR3018685B1 (fr) Applications cosmetiques et pharmaceutiques de la salicaire
WO2021018682A1 (fr) Complexe hybride mineral et organique et son utilisation pour le maintien de l'equilibre microbiologique de la peau et/ou d'une composition cosmetique et/ou dermopharmaceutique
WO2020260611A1 (fr) Extrait de cleome droserifolia et son utilisation therapeutique, ou cosmetique
WO2021001332A1 (fr) Procede d'obtention d'une infusion thermale botanique
EP2367525A1 (fr) Composition comprenant des saponines
FR2988562A1 (fr) Activite antibacterienne de ludwigia peploides
FR2985184A1 (fr) Utilisation cosmetique d'un extrait de banane
FR3013984A1 (fr) Composition a usage topique comprenant au moins un extrait de matricaria recutita avec au moins un adn hautement polymerise, et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180614

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250623

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250623